Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
The New England Journal of Medicine
|
June 11, 1992
Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
A Herskovic, K Martz, M al-Sarraf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study
M al-Sarraf, K Martz, A Herskovic, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 8, 2003
P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003
E Hammond, Brian A Berkey, Karen K Fu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 27, 1998
Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC)
R Komaki, C B Scott, R Byhardt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 12, 2000
Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy
A Trotti, R Byhardt, J Stetz, et al.
Journal of the National Cancer Institute
|
November 28, 1992
Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer
M V Graham, L M Geitz, R Byhardt, et al.
Chest
|
February 12, 2000
Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group
W Sause, P Kolesar, I V Taylor S, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 15, 1995
Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13
K K Fu, T F Pajak, V A Marcial, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 2003
Radiotherapy patterns of care study in lung carcinoma
B Movsas, J Moughan, R Komaki, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 29, 1999
The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies
B Movsas, C Scott, W Sause, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
The New England Journal of Medicine
|
June 11, 1992
Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
A Herskovic, K Martz, M al-Sarraf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study
M al-Sarraf, K Martz, A Herskovic, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 8, 2003
P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003
E Hammond, Brian A Berkey, Karen K Fu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 27, 1998
Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC)
R Komaki, C B Scott, R Byhardt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 12, 2000
Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy
A Trotti, R Byhardt, J Stetz, et al.
Journal of the National Cancer Institute
|
November 28, 1992
Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer
M V Graham, L M Geitz, R Byhardt, et al.
Chest
|
February 12, 2000
Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group
W Sause, P Kolesar, I V Taylor S, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 15, 1995
Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13
K K Fu, T F Pajak, V A Marcial, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 2003
Radiotherapy patterns of care study in lung carcinoma
B Movsas, J Moughan, R Komaki, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 29, 1999
The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies
B Movsas, C Scott, W Sause, et al.
Page
of 3